![]() |
|
|
Department of Anesthesiology and Critical Care Medicine, University Hospital Freiburg Freiburg, Germany (S.E.P., T.L., A.H., R.S., H.L.P., K.K.G., B.H.J.P.), and Institute of Pharmaceutical Biology, Albert-Ludwigs-Universität Freiburg, Freiburg, Germany (C.K.)
Barbiturates are frequently used for the treatment of intracranial hypertension after brain injury but their application is associated with a profound increase in the infection rate. The mechanism of barbiturate-induced failure of protective immunity is still unknown. We provide evidence that nuclear factor of activated T cells (NFAT), an essential transcription factor in T cell activation, is a target of barbiturate-mediated immunosuppression in human T lymphocytes. Treatment of primary CD3+ lymphocytes with barbiturates inhibited the PMA and ionomycin induced increase in DNA binding of NFAT, whereas the activity of other transcription factors, such as Oct-1, SP-1, or the cAMP response element-binding protein, remained unaffected. Moreover, barbiturates suppressed the expression of a luciferase reporter gene under control of NFAT (stably transfected Jurkat T cells), and of the cytokine genes interleukin-2 and interferon-
that contain functional binding motifs for NFAT within their regulatory promotor domains (human peripheral blood CD3+ lymphocytes). Neither GABA receptor-initiated signaling nor direct interactions of barbiturates with nuclear proteins affected the activity of NFAT. In contrast, barbiturates suppressed the calcineurin-dependent dephosphorylation of NFAT in intact T cells and also inhibited the enzymatic activity of calcineurin in a cell-free system, excluding upstream regulation. Thus, our results demonstrate a novel mechanism of direct inhibition of the calcineurin/calmodulin complex that may explain some of the known immunosuppressive effects associated with barbiturate treatment.
Address correspondence to: Dr. Benedikt H. J. Pannen, Anaesthesiologische Universitätsklinik, Hugstetterstrasse 55, D-79106 Freiburg, Germany. E-mail: pannen{at}nz.ukl.uni-freiburg.de
This article has been cited by other articles:
![]() |
M. Roesslein, D. Schibilsky, L. Muller, U. Goebel, C. Schwer, M. Humar, R. Schmidt, K. K. Geiger, H. L. Pahl, B. H. J. Pannen, et al. Thiopental Protects Human T Lymphocytes from Apoptosis in Vitro via the Expression of Heat Shock Protein 70 J. Pharmacol. Exp. Ther., April 1, 2008; 325(1): 217 - 225. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Humar, H. Dohrmann, P. Stein, N. Andriopoulos, U. Goebel, B. Heimrich, M. Roesslein, R. Schmidt, C. I. Schwer, A. Hoetzel, et al. Repression of T-Cell Function by Thionamides Is Mediated by Inhibition of the Activator Protein-1/Nuclear Factor of Activated T-Cells Pathway and Is Associated with a Common Structure Mol. Pharmacol., December 1, 2007; 72(6): 1647 - 1656. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Humar, N. Andriopoulos, S. E. Pischke, T. Loop, R. Schmidt, A. Hoetzel, M. Roesslein, H. L. Pahl, K. K. Geiger, and B. H. J. Pannen Inhibition of Activator Protein 1 by Barbiturates Is Mediated by Differential Effects on Mitogen-Activated Protein Kinases and the Small G Proteins Ras and Rac-1 J. Pharmacol. Exp. Ther., December 1, 2004; 311(3): 1232 - 1240. [Abstract] [Full Text] [PDF] |
||||